EUCTR2015-004328-73-ES进行中（未招募）1 期
Evaluation of efficacy and safety of medroxiprogesterone acetate (Progevera 10 mg®) versus GnRh antagonist (Orgalutran®) in ovarian stimulation cycles of oocyte donors
Fundació Privada EUGIn0 个研究点开始时间: 2016年5月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Oocyte donors included in the oocyte donation program of Clinica EUGIN are healthy women younger than 35 years old with normal ovarian reserve.
- •-1st oocyte donation cycle at Clínica EUGIN.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Polycistic Ovarian syndrome (PCOs).
- •-Estradiol levels on day 2 of menstrual cycle >70 pg/ml.
- •-Hormone treatments up to 3 months before the oocyte donation cycle.
- •-Medical contraindication to the treatments used in the study
研究者
相似试验
招募中
3 期
Effect of Medroxy progesteron in Chronic Obstructive Pulmonary Disease (COPD) exacerbatioChronic Obstructive Pulmonary Disease(COPD) Exacerbation.Chronic obstructive pulmonary disease with acute exacerbation, unspecifiedJ44.1IRCT20211031052922N1Esfahan University of Medical Sciences70
已完成
4 期
Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte DonorsInfertilityNCT02796105Fundació Privada Eugin232
已完成
不适用
on-randomised trial of a lipid lowering drug and a steroid for the treatment of relapsed Burkitt's lymphoma in Blantyre, MalawiDiffuse non-Hodgkin's lymphomaCancerBurkitt's lymphomaISRCTN34303497niversity of Malawi (Malawi)40
招募中
不适用
Examination of efficacy and safety treated by romosozumab or denosumab in osteoporosis with collagen disease including glucocorticoid-induced osteoporosisosteoporosis with collagen disease including glucocorticoid-induced osteoporosisJPRN-UMIN000036837Shinshu University School of Medicine Dept. of Orthopaedic Surgery60
进行中（未招募）
1 期
sefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors which are undergoing controlled ovarian stimulation (COS)EUCTR2017-002341-30-ESINSTITUTO VALENCIANO DE INFERTILIDAD (IVI)318